Skip to Content

BML Inc 4694 Stock Quote

| Rating as of

Morningstar‘s Stock Analysis 4694

Valuation
Currency in JPY
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics 4694

Company Profile 4694

Business Description

BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.

Contact
5-21-3 Sendagaya, Shibuya-ku
Tokyo, 1510051, Japan
T +81 333500111
Industry Diagnostics & Research
Most Recent Earnings Jun 30, 2022
Fiscal Year End Mar 31, 2020
Employees 8,927